{"title":"Fish oil from regional river waste mitigates hepatic steatosis and dyslipidemia in Wistar rats fed high-fat diets","authors":"Jimena Lavandera, Sofía Neville, Daniela Lamas, Valentina Naretto, Claudio Bernal, Juliana Sain","doi":"10.1016/j.cnd.2026.08.027","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/objective</h3><div>The rising prevalence of non-communicable diseases has increased interest in the study of functional foods or ingredients. Therefore, using river fish industry by-products as a source of bioactive lipids represents a promising strategy for preventing metabolic disorders. By taking advantage of this regional resource, this study aimed to evaluate the biological functionality of fish oil (FO) extracted from local fish waste as a source of n-3 PUFAs, focusing on its ability to prevent metabolic dysfunction-associated steatotic liver disease (MASLD) and correct lipid imbalances in a growing murine model fed high-fat diets.</div></div><div>The rising prevalence of non-communicable diseases has increased interest in the study of functional foods or ingredients. Therefore, using river fish industry by-products as a source of bioactive lipids represents a promising strategy for preventing metabolic disorders. By taking advantage of this regional resource, this study aimed to evaluate the biological functionality of fish oil (FO) extracted from local fish waste as a source of n-3 PUFAs, focusing on its ability to prevent metabolic dysfunction-associated steatotic liver disease (MASLD) and correct lipid imbalances in a growing murine model fed high-fat diets.</div><div><h3>Methods</h3><div>Wistar rats (100<!--> <!-->g) (Ethics Committee approval No. CES2024-88) were randomly assigned to four groups (<em>n</em> <!-->=<!--> <!-->6/group) and fed with one of the following diets for 60 days: S7 (control AIN 93G: 7% soybean oil); S30 (30% soybean oil); C30 (27% corn oil<!--> <!-->+<!--> <!-->3% soybean oil); and F30 (27% FO<!--> <!-->+<!--> <!-->3% soybean oil). Body weight and energy intake were monitored. After sacrifice (decapitation), serum lipid profiles, glucose, and transaminases (GOT/GPT) were measured using commercial kits. Liver analysis included total triglycerides (TAG), cholesterol, fatty acid (FA) profile (gas chromatography), and mRNA expression of lipogenic and β-oxidation markers (RT-qPCR). Statistical analysis was performed using ANOVA and Tukey's test (<em>P</em> <!--><<!--> <!-->0.05).</div></div><div>Wistar rats (100<!--> <!-->g) (Ethics Committee approval No. CES2024-88) were randomly assigned to four groups (<em>n</em> <!-->=<!--> <!-->6/group) and fed with one of the following diets for 60 days: S7 (control AIN 93G: 7% soybean oil); S30 (30% soybean oil); C30 (27% corn oil<!--> <!-->+<!--> <!-->3% soybean oil); and F30 (27% FO<!--> <!-->+<!--> <!-->3% soybean oil). Body weight and energy intake were monitored. After sacrifice (decapitation), serum lipid profiles, glucose, and transaminases (GOT/GPT) were measured using commercial kits. Liver analysis included total triglycerides (TAG), cholesterol, fatty acid (FA) profile (gas chromatography), and mRNA expression of lipogenic and β-oxidation markers (RT-qPCR). Statistical analysis was performed using ANOVA and Tukey's test (<em>P</em> <!--><<!--> <!-->0.05).</div><div><h3>Results</h3><div>High-fat diets (S30, C30, F30) significantly increased thoracic circumference and energy intake compared to S7. While S30 and C30 groups developed hepatic steatosis with significantly higher liver TAG levels, F30 effectively mitigated this effect, maintaining liver TAG at control (S7) levels. F30 significantly reduced serum total cholesterol, LDL-cholesterol, and HDL-cholesterol compared to other groups. Furthermore, F30 treatment modulated liver metabolism by downregulating acetyl-CoA carboxylase (ACC) mRNA expression and improving the FA n-6/n-3 ratio through significant incorporation of EPA (20:5 n-3) and DHA (22:6 n-3) into hepatic tissue. GOT levels were also reduced in the F30 group compared to S7.</div></div><div>High-fat diets (S30, C30, F30) significantly increased thoracic circumference and energy intake compared to S7. While S30 and C30 groups developed hepatic steatosis with significantly higher liver TAG levels, F30 effectively mitigated this effect, maintaining liver TAG at control (S7) levels. F30 significantly reduced serum total cholesterol, LDL-cholesterol, and HDL-cholesterol compared to other groups. Furthermore, F30 treatment modulated liver metabolism by downregulating acetyl-CoA carboxylase (ACC) mRNA expression and improving the FA n-6/n-3 ratio through significant incorporation of EPA (20:5 n-3) and DHA (22:6 n-3) into hepatic tissue. GOT levels were also reduced in the F30 group compared to S7.</div><div><h3>Conclusion</h3><div>Fish oil extracted from regional river waste is a functional ingredient that prevents hepatic lipid accumulation and dyslipidemia. These effects are mediated by the modulation of a key lipogenic enzyme and the successful incorporation of n-3 PUFAs into tissues, supporting its potential use in functional foods for human health.</div></div><div>Fish oil extracted from regional river waste is a functional ingredient that prevents hepatic lipid accumulation and dyslipidemia. These effects are mediated by the modulation of a key lipogenic enzyme and the successful incorporation of n-3 PUFAs into tissues, supporting its potential use in functional foods for human health.</div>","PeriodicalId":43722,"journal":{"name":"CAHIERS DE NUTRITION ET DE DIETETIQUE","volume":"61 ","pages":"Pages e15-e16"},"PeriodicalIF":0.3000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CAHIERS DE NUTRITION ET DE DIETETIQUE","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0007996026001033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background/objective
The rising prevalence of non-communicable diseases has increased interest in the study of functional foods or ingredients. Therefore, using river fish industry by-products as a source of bioactive lipids represents a promising strategy for preventing metabolic disorders. By taking advantage of this regional resource, this study aimed to evaluate the biological functionality of fish oil (FO) extracted from local fish waste as a source of n-3 PUFAs, focusing on its ability to prevent metabolic dysfunction-associated steatotic liver disease (MASLD) and correct lipid imbalances in a growing murine model fed high-fat diets.
The rising prevalence of non-communicable diseases has increased interest in the study of functional foods or ingredients. Therefore, using river fish industry by-products as a source of bioactive lipids represents a promising strategy for preventing metabolic disorders. By taking advantage of this regional resource, this study aimed to evaluate the biological functionality of fish oil (FO) extracted from local fish waste as a source of n-3 PUFAs, focusing on its ability to prevent metabolic dysfunction-associated steatotic liver disease (MASLD) and correct lipid imbalances in a growing murine model fed high-fat diets.
Methods
Wistar rats (100 g) (Ethics Committee approval No. CES2024-88) were randomly assigned to four groups (n = 6/group) and fed with one of the following diets for 60 days: S7 (control AIN 93G: 7% soybean oil); S30 (30% soybean oil); C30 (27% corn oil + 3% soybean oil); and F30 (27% FO + 3% soybean oil). Body weight and energy intake were monitored. After sacrifice (decapitation), serum lipid profiles, glucose, and transaminases (GOT/GPT) were measured using commercial kits. Liver analysis included total triglycerides (TAG), cholesterol, fatty acid (FA) profile (gas chromatography), and mRNA expression of lipogenic and β-oxidation markers (RT-qPCR). Statistical analysis was performed using ANOVA and Tukey's test (P < 0.05).
Wistar rats (100 g) (Ethics Committee approval No. CES2024-88) were randomly assigned to four groups (n = 6/group) and fed with one of the following diets for 60 days: S7 (control AIN 93G: 7% soybean oil); S30 (30% soybean oil); C30 (27% corn oil + 3% soybean oil); and F30 (27% FO + 3% soybean oil). Body weight and energy intake were monitored. After sacrifice (decapitation), serum lipid profiles, glucose, and transaminases (GOT/GPT) were measured using commercial kits. Liver analysis included total triglycerides (TAG), cholesterol, fatty acid (FA) profile (gas chromatography), and mRNA expression of lipogenic and β-oxidation markers (RT-qPCR). Statistical analysis was performed using ANOVA and Tukey's test (P < 0.05).
Results
High-fat diets (S30, C30, F30) significantly increased thoracic circumference and energy intake compared to S7. While S30 and C30 groups developed hepatic steatosis with significantly higher liver TAG levels, F30 effectively mitigated this effect, maintaining liver TAG at control (S7) levels. F30 significantly reduced serum total cholesterol, LDL-cholesterol, and HDL-cholesterol compared to other groups. Furthermore, F30 treatment modulated liver metabolism by downregulating acetyl-CoA carboxylase (ACC) mRNA expression and improving the FA n-6/n-3 ratio through significant incorporation of EPA (20:5 n-3) and DHA (22:6 n-3) into hepatic tissue. GOT levels were also reduced in the F30 group compared to S7.
High-fat diets (S30, C30, F30) significantly increased thoracic circumference and energy intake compared to S7. While S30 and C30 groups developed hepatic steatosis with significantly higher liver TAG levels, F30 effectively mitigated this effect, maintaining liver TAG at control (S7) levels. F30 significantly reduced serum total cholesterol, LDL-cholesterol, and HDL-cholesterol compared to other groups. Furthermore, F30 treatment modulated liver metabolism by downregulating acetyl-CoA carboxylase (ACC) mRNA expression and improving the FA n-6/n-3 ratio through significant incorporation of EPA (20:5 n-3) and DHA (22:6 n-3) into hepatic tissue. GOT levels were also reduced in the F30 group compared to S7.
Conclusion
Fish oil extracted from regional river waste is a functional ingredient that prevents hepatic lipid accumulation and dyslipidemia. These effects are mediated by the modulation of a key lipogenic enzyme and the successful incorporation of n-3 PUFAs into tissues, supporting its potential use in functional foods for human health.
Fish oil extracted from regional river waste is a functional ingredient that prevents hepatic lipid accumulation and dyslipidemia. These effects are mediated by the modulation of a key lipogenic enzyme and the successful incorporation of n-3 PUFAs into tissues, supporting its potential use in functional foods for human health.
期刊介绍:
Les Cahiers de nutrition et de diététique sont le lieu de communication reconnu pour les médecins spécialistes de la nutrition, les diététiciens, les professionnels et les chercheurs de agro-alimentaire, les enseignants et les étudiants. Les Cahiers de nutrition et de diététique abordent les sujets se rapportant à la biologie générale, à la médecine et à la nutrition, aux aliments, aux comportements alimentaires, à la diététique pratique, ainsi que des thèmes variés : activité physique, apports nutritionnels conseillés, dénutrition, alcool, obésité de enfant, aliments à effet santé, plaisir alimentaire, restauration collective, goûters et collations, allergies alimentaires...